drugset / Trial / NCT02955693
Study of the Effects of the Organism on Monomethyl Fumarate (MMF) After the Administration of LAS41008
RandomizedCrossoverOpen-labelTreatment
Summary
The purpose of this study is to determine how the organism affects MMF (metabolite of dimethyl fumarate \[DMF\]) after single oral dose administration of LAS41008 120 mg gastroresistant tablet and Fumaderm® 120 mg gastro-resistant tablet under fasting and fed conditions. The study also aims to assess the safety of the study treatments.
Timeline
- Start
- 2016-09
- Primary completion
- 2016-10
- Completion
- 2016-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fumaric acid | Small molecule | 120 mg | — |
| Subject | dimethyl fumarate | Unknown | 120 mg | — |